BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 6254416)

  • 1. Malignant glucagonoma syndrome: response to chemotherapy.
    Marynick SP; Fagadau WR; Duncan LA
    Ann Intern Med; 1980 Sep; 93(3):453-4. PubMed ID: 6254416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dimethyltriazenoimidazole carboxamide therapy of islet cell carcinoma of the pancreas.
    Awrich AE; Peetz M; Fletcher WS
    J Surg Oncol; 1981; 17(4):321-6. PubMed ID: 6267376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of a somatostatin analog (SMS 201-995) in the glucagonoma syndrome.
    Altimari AF; Bhoopalam N; O'Dorsio T; Lange CL; Sandberg L; Prinz RA
    Surgery; 1986 Dec; 100(6):989-96. PubMed ID: 2878500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unsuccessful DTIC treatment of a patient with glucagonoma syndrome.
    Hallengren B; Dymling JF; Manhem P; Tennvall L; Tibblin S
    Acta Med Scand; 1983; 213(4):317-8. PubMed ID: 6310975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A functional study of a case of glucagonoma exhibiting typical glucagonoma syndrome.
    Fujita J; Seino Y; Ishida H; Taminato T; Matsukura S; Horio T; Imamura S; Naito A; Tobe T; Takahashi K
    Cancer; 1986 Feb; 57(4):860-5. PubMed ID: 2867823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful treatment of glucagonoma-related necrolytic migratory erythema with dacarbazine.
    van der Loos TL; Lambrecht ER; Lambers JC
    J Am Acad Dermatol; 1987 Feb; 16(2 Pt 2):468-72. PubMed ID: 3029193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Metastatic glucagonoma. Complete remission by dacarbazine (5 years' recession)].
    Jeanmougin M; Civatte J; Bonvalet D; Passa P; Verola O; Zylberait D
    Ann Dermatol Venereol; 1988; 115(8):833-8. PubMed ID: 2849362
    [No Abstract]   [Full Text] [Related]  

  • 8. Successful treatment of metastatic glucagonoma with dacarbazine.
    Kurose T; Seino Y; Ishida H; Fujita J; Taminato T; Matsukura M; Imura H
    Lancet; 1984 Mar; 1(8377):621-2. PubMed ID: 6142319
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunologic characterization of plasma glucagon components in a patient with malignant glucagonoma.
    Tanaka K; Watabe T; Shimizu N; Horiuchi T; Nakamura K; Yoshida H
    Metabolism; 1984 Aug; 33(8):728-33. PubMed ID: 6087085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Octreotide (SMS 201-995) in the treatment of metastatic glucagonoma: report of one case and review of the literature.
    Rosenbaum A; Flourie B; Chagnon S; Blery M; Modigliani R
    Digestion; 1989; 42(2):116-20. PubMed ID: 2548911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucagonoma and dacarbazine.
    Duncan LA; Marynick SP
    Ann Intern Med; 1982 Dec; 97(6):930. PubMed ID: 6293359
    [No Abstract]   [Full Text] [Related]  

  • 12. Operative and chemotherapeutic management of malignant glucagon-producing tumors.
    Prinz RA; Badrinath K; Banerji M; Sparagana M; Dorsch TR; Lawrence AM
    Surgery; 1981 Oct; 90(4):713-9. PubMed ID: 6269242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Necrolytic migratory erythema and glucagon cell tumour of the pancreas: the glucagonoma syndrome. Report of two cases.
    Pedersen NB; Jonsson L; Holst JJ
    Acta Derm Venereol; 1976; 56(5):391-5. PubMed ID: 78626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapy of metastatic carcinoid and islet cell tumors. A review.
    Kvols LK; Buck M
    Am J Med; 1987 May; 82(5B):77-83. PubMed ID: 3035924
    [No Abstract]   [Full Text] [Related]  

  • 15. Streptozotocin effective for treating multiple-hormone-producing malignant islet cell tumor.
    Murata E; Tashiro S; Hiraoka T
    Jpn J Surg; 1985 Jan; 15(1):63-7. PubMed ID: 2985854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The glucagonoma syndrome.
    Sonksen PH; Bloom SR
    J R Soc Med; 1990 Feb; 83(2):127. PubMed ID: 1969482
    [No Abstract]   [Full Text] [Related]  

  • 17. The glucagonoma syndrome and its management.
    Kessinger A; Lemon HM; Foley JF
    J Surg Oncol; 1977; 9(5):419-24. PubMed ID: 201809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrobulbar neuritis as the first sign of the glucagonoma syndrome.
    Lambrecht ER; van der Loos TL; van der Eerden AH
    Int Ophthalmol; 1987 Oct; 11(1):13-5. PubMed ID: 2826358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DTIC therapy in patients with malignant intra-abdominal neuroendocrine tumors.
    Altimari AF; Badrinath K; Reisel HJ; Prinz RA
    Surgery; 1987 Dec; 102(6):1009-17. PubMed ID: 2825370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucagonoma syndrome. Report of two cases and literature review.
    Binnick AN; Spencer SK; Dennison WL; Horton ES
    Arch Dermatol; 1977 Jun; 113(6):749-54. PubMed ID: 194536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.